Advertisement

Virchows Archiv A

, Volume 389, Issue 3, pp 325–341 | Cite as

Polycythemia vera

II. Transgression towards leukemia with special emphasis on histological differential diagnosis, cytogenetics and survival
  • K. F. Vykoupil
  • J. Thiele
  • W. Stangel
  • E. Krmpotic
  • A. Georgii
Article

Summary

Of 113 Patients with polycythemia vera (P. vera) who had been followed for the last 8 years, 30 cases (27%) developed myeloid leukemia with fibrosis of the bone marrow. Core biopsies of the bone marrow including sequential examinations in several cases revealed neoplastic proliferation of neutrophil granulopoiesis and an atypical megakaryopoiesis with accompanying fibrosis of varying degrees. These alterations were consistent with a subtype of chronic myeloid leukemia — the so called chronic megakaryocytic-granulocytic myelosis (CMGM) — and correspond to (agnogenic) myeloid metaplasia with osteomyelofibrosis/-sclerosis. 5 of those 30 patients showed spontaneous transgression into myeloid leukemia, none of them had received any ionizing radiation or cytostatic therapy. A blast crisis or so called acute leukemia in P. vera was seen only in one patient who was treated by an overdose of radioactive phosphorus and later evolved into osteomyelosclerosis with blastic transformation.

These findings of a chronic leukemia or CMGM arising from P. vera was further confirmed by atypia of ultrastructure and particularly by our cytogenetic evaluation. Chromosomal studies showed a Ph′-chromosome to be present in 5 of 8 patients with CMGM and myelofibrosis.

Clinical and statistical evaluation of survival times showed a median survival expectation of all P. vera patients of 15 years. Life expectancy of the patients who still displayed P. vera was more favorable than those cases with transformation into CMGM, disregarding any therapy. Transformation of P. vera into CMGM occurred about 8 years after the onset of disease and following transgression into leukemia, half of these patients were dead after 2.5 years. Our results demonstrate that P. vera represents a “panmyelosis” with an inherent malignant nature, or a neoplastic proliferation of all three cell lines. This concept is supported by several facts: atypia of cytological differentiation as observed by light- and electron microscopy of the bone marrow, chromosomal anomalies with aneuploidy and an infrequent Ph'-marker, spontaneous transgression into chronic myeloid leukemia or its subtype CMGM without relevant therapy and a clonal evolution as shown by enzymatic studies reported in the literature.

Key words

Polycythemia vera Myeloid leukemia Histopathology Ultrastructure Cytogenetics Survival 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L (1976) Polycythemia vera: stem cell and probable clonal origin of the disease. N Engl J Med 295:913–916Google Scholar
  2. Barr RD, Fialkow PJ (1973) Clonal origin of chronic myelocytic leukemia. N Engl J Med 289:307–309Google Scholar
  3. Burkhardt R, Pabst W, Kleber A (1969) Knochenmark-Histologie und Klinik der Polycythaemia vera. Arch Klin Med 216:64–104Google Scholar
  4. Burkhardt R, Cirl Chr, Bartl R, Jäger K (1979) 193 histobioptic case controls in 58 polycythemic patients in the course of 2–15 years. Int Soc Haematol Congr, August 26–31, Hamburg, 1979Google Scholar
  5. Cutter SJ, Ederer F (1958) Maximum utilization of the life table method in analyzing survival. J Chr Dis 8:699–713Google Scholar
  6. Duhamel G, Najman A, André R (1970) L'histologie de la moelle osseuse dans la maladie de Vaquez et le problème de la myélosclérose. A propos de 70 biopsies. Nouv Rev Franc Hématol 10:209–222Google Scholar
  7. Ellis JT, Peterson P (1979) The bone marrow in polycythemia vera. Pathol Annu 14:383–403Google Scholar
  8. Fialkow PJ, Jacobson RJ, Papayannopoulou T (1977) Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63:125–130Google Scholar
  9. Georgii A (1979) Histopathology of bone marrow in human chronic leukemias. In: Neth R, Gallo RC, Hofschneider H-P, Mannweiler K (eds) Modern trends in human leukemia III. Newest results in clinical and biological research. Springer, Berlin-Heidelberg-New York, p 59–70Google Scholar
  10. Halnan KE, Russell MH (1965) Polycythaemia vera. Comparison of survival and causes of death in patients managed with and without radiotherapy. Lancet 16:760–763Google Scholar
  11. Hoppin EC, Lewis JP (1975) Polycythemia vera rubra progressing to Ph'-positive chronic myelogenous leukemia. Ann Int Med 83:820–823Google Scholar
  12. Ikkala E, Rapola J, Kotilainen M (1967) Polycythaemia vera and myelofibrosis. Scand J Haematol 4:453–464Google Scholar
  13. Jacobson RJ, Salo A, Fialkow PJ (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 51:189–194Google Scholar
  14. Kirkland DJ, Welch SG, Povey S, Najfeld V, Price DJ, Lawler SD (1980) Glutamic pyruvate transaminase phenotypes in polycythaemia vera. Br J Haematol 44:407–413Google Scholar
  15. Landaw SA (1976) Acute leukemia in polycythemia vera. Sem Hematol 13:33–43Google Scholar
  16. Laszlo J (1975) Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 12:409–432Google Scholar
  17. Lennert K, Nagai K, Schwarze E-W (1975) Patho-anatomical features of the bone marrow in polycythaemia and myelofibrosis. Clin Haematol 4:331–351Google Scholar
  18. Lopas H, Josephson AM (1964) Myeloproliferative syndrome: evaluation of myelosclerosis and chronic myelogenous leukemia to polycythemia vera. Arch Int Med 114:754–759Google Scholar
  19. Lundin PM, Ridell B, Weinfeld A (1972) The significance of bone marrow morphology for the diagnosis of polycythaemia vera. Scand J Haematol 9:271–282Google Scholar
  20. Masouredis SP, Lawrence JH (1957) The problem of leukemia in polycythemia vera. Am J Med Sci 233:268–274Google Scholar
  21. Meytes D, Katz D, Ramot B (1976) Preleukemia and leukemia in polycythemia vera. Blood 47:237–241Google Scholar
  22. Modan B, Modan M (1968) Benign erythrocytosis. Br J Haematol 14:375–381Google Scholar
  23. Modan B (1975) Inter-relationship between polycythaemia vera, leukaemia and myeloid metaplasia. Clin Haematol 4:427–439Google Scholar
  24. Prchal JF, Adamson JW, Murphy S, Steinmann L, Fialkow PJ (1978) Polycythemia vera: the in vitro response of normal and abnormal stem cell lines to erythropoietin. J Clin Invest 61:1044–1047Google Scholar
  25. Roberts BE, Miles DW, Woods CG (1969) Polycythaemia vera and myelosclerosis: a bone marrow study. Br J Haematol 16:75–85Google Scholar
  26. Rowley JD (1976) The role of cytogenetics in hematology. Blood 48:1–7Google Scholar
  27. Rosenthal DS, Moloney WC (1977) Occurrence of acute leukaemia in myeloproliferative disorders. Br J Haematol 36:373–382Google Scholar
  28. Silverstein MN (1974) Postpolycythemia myeloid metaplasia. Arch Intern Med 134:113–115Google Scholar
  29. Silverstein MN (1976) The evolution into and the treatment of late stage polycythemia vera. Semin Hematol 13:79–84Google Scholar
  30. Singer JW, Fialkow PJ, Adamson JW, Steinmann L, Ernst C, Murphy S, Kopecky KJ (1979) Polycythemia vera. Increased expression of normal comitted granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine. J Clin Invest 64:1320–1324Google Scholar
  31. Schwartz SO, Ehrlich L (1950) The relationship of polycythemia vera to leukemia: a critical review. Acta Haematol 4:129–147Google Scholar
  32. Thiele J, Stangel W, Vykoupil KF, Georgii A (1979) Polycythemia vera: electron microscopy of the bone marrow in 10 non-treated patients. A thin section and freeze-fracture study. Blut 38:407–420Google Scholar
  33. Vykoupil KF, Thiele J, Stangel W, Krmpotic E, Georgii A (1980) Polycythemia vera: I. Histopathology, ultrastructure and cytogenetics of the bone marrow in comparison with secondary polycythemia. Virchows Arch A Pathol Anat and Histol 389:307–324Google Scholar
  34. Wasserman LR (1976) The treatment of polycythemia vera. Semin Hematol 13:57–78Google Scholar
  35. Weinfeld A, Westin J, Ridell B, Swolin B (1977) Polycythaemia vera terminating in acute leukaemia. A clinical, cytogenetic and morphologic study in 8 patients treated with alkylating agents. Scand J Haematol 19:255–272Google Scholar
  36. Wurster-Hill DH, McIntyre OR (1978) Chromosome studies in polycythemia vera. Virchows Arch B Cell Path 29:39–44Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • K. F. Vykoupil
    • 1
  • J. Thiele
    • 1
  • W. Stangel
    • 2
  • E. Krmpotic
    • 1
  • A. Georgii
    • 1
  1. 1.Institute of PathologyMedical School HannoverHannover 61Germany
  2. 2.Department of Immunology and Blood TransfusionMedical School HannoverHannover 61Germany

Personalised recommendations